Skip to main content
The Globe and Mail
Support Quality Journalism.
The Globe and Mail
First Access to Latest
Investment News
Collection of curated
e-books and guides
Inform your decisions via
Globe Investor Tools
Just$1.99
per week
for first 24 weeks

Enjoy unlimited digital access
Enjoy Unlimited Digital Access
Get full access to globeandmail.com
Just $1.99 per week for the first 24 weeks
Just $1.99 per week for the first 24 weeks
var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(select.open)}function setPanelState(o){dom.root.classList[o?"add":"remove"](select.open),dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){window.requestAnimationFrame(function() {var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))});}pencilInit(".js-sub-pencil",!1); // via darwin-bg var slideIndex = 0; carousel(); function carousel() { var i; var x = document.getElementsByClassName("subs_valueprop"); for (i = 0; i < x.length; i++) { x[i].style.display = "none"; } slideIndex++; if (slideIndex> x.length) { slideIndex = 1; } x[slideIndex - 1].style.display = "block"; setTimeout(carousel, 2500); } //

B.C. is the only province where the rate of new HIV infections is falling steadily and markedly. B.C. is also the only province that offers highly active anti-retroviral therapy (HAART) free of charge and aggressively promotes its use.

Coincidence? Not at all.

New research published in Wednesday's edition of the medical journal Public Library of Science One shows that for every 10-per-cent increase in the number of HIV-positive patients taking HAART, new HIV diagnoses fell 8 per cent – pretty close to a perfect correlation.

Story continues below advertisement

These are some of the most compelling data to date demonstrating the soundness of the "treatment as prevention" theory, an approach conceived at the B.C. Centre for Excellence in HIV-AIDS and now being embraced worldwide.

Treatment as prevention – or TaP for short, because in the world of HIV-AIDS, acronyms are de rigeur – is so successful, from Zimbabwe to Abbottsford, that policy-makers now talk openly about the possibility of freezing the epidemic in its tracks and creating an AIDS-free generation.

As is too often the case though, Canadians are slow to embrace Canadian innovation.

Consider that a young man diagnosed today as HIV-positive at age 20 and placed on HAART can expect to live to age 73, a life expectancy near normal.

By taking a cocktail of medication that suppresses replication of the virus, this man will have little likelihood of passing it on to his sexual partner(s).

That, of course, is the goal: To stop new infections, in addition to keeping those who are already infected from falling prey to killer opportunistic infections.

Development of an AIDS vaccine is proving to be bedevilling, so TaP remains the closest thing we have. Of course, it is an adjunct, not a replacement for other preventive actions such as use of condoms and harm-reduction measures like supervised drug injection.

Story continues below advertisement

Treating HIV-positive pregnant women with HAART is nearly 100-per-cent effective in preventing transmission of the AIDS virus to their babies. In discordant couples – where one partner is infected and the other is not – infection rates fall 95 per cent if the HIV-positive partner takes HAART. But if treatment as prevention is going to be fully effective, it is essential to get as many HIV-positive people as possible on it.

For that to happen, two measures are required : Universal testing and free treatment.

In the world, B.C. is the jurisdiction that is closest to achieving this goal and it is reaping the rewards. Since the advent of HAART in 1996, AIDS deaths in the province are down 90 per cent and new diagnoses down 65 per cent.

Why isn't every province and territory following B.C.'s lead? Shouldn't an AIDS-free generation be a national goal?

An estimated 65,000 Canadians live with HIV-AIDS. Despite all the prevention efforts, 3,300 new cases are diagnosed annually.

About one in four Canadians who are HIV-positive don't know it, according to the Public Health Agency of Canada, and the unaware are likely responsible for most of the new cases.

Story continues below advertisement

At this point, the only way to reduce infections is a "seek and treat" strategy, to use public health jargon.

No one is suggesting that HIV testing be mandatory. But it should be easy and routine. All blood donations in Canada are tested for HIV, and so are pregnant women, but that policy has not extended to all sexually active adults.

Research shows the most effective method is asking every patient who comes into ER, hospital or goes to the doctor: "Do you want to confirm you're HIV-negative?" In a pilot project conducted in Vancouver, 92 per cent of patients answered "Yes." More importantly, six in every 1,000 patients tested turned out to be HIV-positive. According to researchers, a rate of one in 1,000 or higher makes the policy cost-effective.

HAART is expensive – about $10,000 a year in Canada – but it is cheaper than treating people for AIDS. And the more people are treated appropriately, the lower the rate of illness and new infections.

Guidelines call for treatment to begin once an HIV-positive person has a CD4 count of 350 or lower. (CD4 is a measure of the strength of the immune system.) That's roughly half of the infected, although the figure will increase over time as survival increases.

B.C. is treating 45 per cent of the HIV-positive – nearly everyone eligible, but not quite. In Quebec, the rate is 37 per cent, and Ontario 35 per cent. (Among them, the three big provinces account for 86 per cent of all HIV-AIDS cases.) Detailed treatment data are not available for other provinces, but we do know new diagnoses are growing at the fastest rate in Saskatchewan.

Story continues below advertisement

Universal testing is not a panacea. But it can and should be the beginning of a cascade of treatment and care.

When we speak of the beginning of the end of AIDS – as scientists now do cautiously – universal "seek and treat" is that beginning.

B.C. is blazing a trail. But others are not following near quickly enough.

Your Globe

Build your personal news feed

  1. Follow topics and authors relevant to your reading interests.
  2. Check your Following feed daily, and never miss an article. Access your Following feed from your account menu at the top right corner of every page.

Follow the author of this article:

View more suggestions in Following Read more about following topics and authors
Report an error Editorial code of conduct
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

If you do not see your comment posted immediately, it is being reviewed by the moderation team and may appear shortly, generally within an hour.

We aim to have all comments reviewed in a timely manner.

Comments that violate our community guidelines will not be posted.

Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies